1Svendsen CN, Smith AG. New prospects for human stem-cell therapy in the nervous system. Trends Neurosci,1999,22(8):357-364.
2Gepstein L. Derivation and potential applications of human embryonic stem cells. Circ Res, 2002,91(10):866-876.
3Thomson JA, ltskovitz-Eldor J,Shapiro SS, et al. Embryonic stem cells derived from human blastocysts. Science,1998,282(5391):1145-1147.
4Shamblott M J, Axelman J, Wang S, et al. Derivation of pluripotent stem cells from cultured human primordialgerm cells. Proc Natl Acad Sci U S A, 1998,95(23): 13726-137231.
5Nakatsuji N, Suemori H. Embryonic stem cell lines of nonhuman primates.Sci World J, 2002,2(6):1762-1773.
6Amit M, Carpenter MK, Inokuma MS, et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol, 2000, 227(2):271-278.
7Inzunza J, Sahlen S, Holmberg K, et al. Comparative genomic hybridization and Karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric X chromosome after long-tern cultivation. Mol Hum Reprod,2004,10(6):461-466.
8Guido de Wert, Christine Mummery. Human embryonic stem cells:research, ethics and policy. Hum Reprod,2003,18(4):672-682.
9Anneren C, Cowan CA, Melton DA. The Src family of tyrosine kinases is important for embryonic stem cell self-renewal. J Biol Chem, 2004,279(30):31590-31598.
10Sato N, Meijer L, Skaltsounis L, et al. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med,2004,10( 1 ):55-63.
